Counterfeit medicines and market integrity: Strengthening regulatory intelligence through predictive analytics and cross-sector collaboration
Bibliographic record
Abstract
The proliferation of counterfeit and substandard medicines poses a persistent global threat to public health, eroding trust in pharmaceutical systems and undermining therapeutic outcomes. This challenge is particularly severe in emerging markets, where fragmented supply chains, limited regulatory capacity, and data silos hinder effective detection and enforcement. This paper explores how predictive analytics and cross-sector collaboration can transform regulatory intelligence and restore market integrity in the global pharmaceutical trade. Through a synthesis of global regulatory initiatives and data-driven frameworks, we highlight the role of artificial intelligence (AI), machine learning (ML), and big data integration in identifying anomalies across manufacturing, importation, and retail distribution channels. Predictive models—such as risk-based surveillance algorithms and supply-chain pattern recognition—enable regulators to proactively detect counterfeiting networks and anticipate supply vulnerabilities. Case examples from the World Health Organization’s Global Surveillance and Monitoring System, the African Medicines Agency (AMA), and the FDA’s Sentinel Initiative illustrate how data-driven regulation enhances transparency, accountability, and rapid response capacity. Furthermore, the paper examines the ethical and governance implications of data sharing among pharmaceutical companies, customs agencies, and digital commerce platforms, emphasizing the need for harmonized regulatory intelligence frameworks. We propose a multi-sector model that integrates AI-enabled detection systems, cross-border data exchange protocols, and public–private partnerships to achieve equitable and sustainable pharmaceutical oversight. Strengthening regulatory intelligence through predictive analytics not only deters counterfeit activity but also reinforces public confidence, global trade reliability, and health equity across nations. Keywords: Counterfeit Medicine, Predictive Analysis, Market Integrity.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.033 | 0.053 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.005 | 0.004 |
| Science and technology studies | 0.003 | 0.010 |
| Scholarly communication | 0.018 | 0.026 |
| Open science | 0.003 | 0.016 |
| Research integrity | 0.004 | 0.005 |
| Insufficient payload (model declined to judge) | 0.003 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".